TABLE 1.
Strains used in this study.
| Microorganism | Strain | Plasmid | Antibiotic resistance | References |
| Micrococcus luteus | 2665 | Furazolidone, Nalidixic acid, Colistin (all at 10 μg/ml) | Rokem et al., 2011 | |
| Staphylococcus epidermidis | 1457 | Nalidixic acid, Colistin (all at 10 μg/ml) | Galac et al., 2017 | |
| Staphylococcus epidermidis | 1457 | pSB2019-gfp | Chloramphenicol, Nalidixic acid, Colistin (all at 10 μg/ml) | This study |
| Staphylococcus aureus | SH1000 | pSB2019-gfp | Chloramphenicol, Nalidixic acid, Colistin (all at 10 μg/ml) | This study |
| Staphylococcus aureus | SH1000 | pmKAT | Erythromycin (20 μg/ml) Nalidixic acid, Colistin (both at 10 μg/ml) | This study |
| Staphylococcus aureusΔagr | SH1000 | Tetracycline, Nalidixic acid, Colistin (all at 10 μg/ml) | This study | |
| Pseudomonas aeruginosa | PAO1-Nottingham | pME6032-mCherry | Tetracycline (125 μg/ml) | Heeb et al., 2000; |
| Ortori et al., 2011 |